This site is intended for healthcare professionals only
LoginRegister
IPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIAIPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIA
Lupin Nagpur facility completes USFDA inspectionLupin Diagnostics unveils Regional Reference Laboratory in Bengaluru
Sanofi DupixentAstraZeneca, Sanofi, Sobi simplify contractual agreements for Nirsevimab
JnJ talc unit faces skepticism on bankruptcy settlement supportJnJ talc unit faces skepticism on bankruptcy settlement support
Flu vaccine did not meet criteria for early success in late-stage trial: ModernaFlu vaccine did not meet criteria for early success in late-stage trial: Moderna
Moderna fends off Arbutus appeal in COVID vaccine patent fightModerna fends off Arbutus appeal in COVID vaccine patent fight
USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infectionsUSFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections
Lupin Gets CDSCO Panel Nod for Phase IV CT of pulmonary FDC drugLupin Gets CDSCO Panel Nod for Phase IV CT of pulmonary FDC drug
Supreme Court Refuses PIL on Medical Syllabus, Asks to Approach the University or GovernmentSC dismisses plea seeking CBI probe against 10 pharma cos for selling Remdesivir, Favipiravir...
USFDA nod to JnJ Tremfya for Crohns diseaseJohnson and Johnson talc unit 2nd bankruptcy must be dismissed, cancer victims' lawyers say
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Medicare Psoriatic arthritis drug Apremilast gets USFDA okay
Pfizer, Biogen among hundreds of US drugmakers calling for abortion pill Mifepristone ruling reversalPfizer, Biogen among hundreds of US drugmakers calling for abortion pill Mifepristone ruling...
X